“Oxford Gene Technology (OGT), The Molecular Genetics Company, has entered into a deal with Baylor Miraca Genetics Laboratories (BMGL), licensing the use of OGT’s proprietary single nucleotide polymorphism (SNP) array probe technology. This novel technology overcomes the limitations of restricti
“For infants and young children, ritonavir-boosted lopinavir-based therapy had been recommended as first-line antiretroviral therapy, while efavirenz was the suggested first-line regimen in adults and older children. Advantages of the latter regimen include once-daily dosing, simplification of co-
“FDA) cautioned against using a minimally invasive method to treat fibroid tumors called power morcellation, there was a nearly quarter increase in hospital readmissions and 27 percent increase in major postoperative complications after hysterectomies in Michigan, a new University of Michigan stud
“Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis (ECTRIMS) congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a (Rebif®) in relapsing form
“Researchers have found an association between treatment with the antibiotic dicloxacillin and a decrease in international normalized ratio (INR; a measure of blood coagulation) levels among patients taking the vitamin K antagonists warfarin or phenprocoumon, according to a study in the July 21 is
“announced that new data being presented at the 23rd World Congress of Dermatology shows aerosol foam Enstilar® (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g), the Company's dual-action investigational aerosol foam for the treatment of psoriasis vulgaris, provided rapid itch
“Babies treated for symptomatic cytomegalovirus (CMV) infection for six months, instead of the standard six weeks, have better hearing and developmental outcomes, according to a new study from the University of Alabama at Birmingham. One in 150 babies will be born with CMV, and about one of every
Facebook detox for reduced stress and increased happiness
Novel strategy to predict antigenic evolution of circulating influenza viruses
New Center for Nano Science and Technology: Italy
Tetra begins human Phase 1 safety trials of BPN14770
Adaptimmune’s NY-ESO-1 TCR-engineered T-cell therapy mediates sustained antitumor effects in multiple myeloma patients
Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease
Giving antibiotics early can reduce risk of severe lower respiratory tract illness in children
Baylor Miraca Genetics Laboratories licenses SNP probe technology from OGT
Study evaluates effectiveness of antiretroviral treatment in HIV-infected children
Number of women receiving minimally invasive hysterectomies goes down after FDA safety communication
Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients
Swedish study reveals combined effects of smoking and early menopause on overall mortality
Study examines link between use of diabetes drug pioglitazone and increased risk of bladder cancer
Use of dicloxacillin linked to INR decrease in patients taking vitamin K antagonists-for-treatment-of-adult-patients-with-nr-axial-SpA.aspx)
MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA
Higher adenoma detection rates linked to lower lifetime colorectal cancer incidence and death
FDA accepts BiondVax's IND for Multimeric-001 vaccine
Molecular classifications of low-grade gliomas proposed
LEO Pharma reports encouraging data from PSO-FAST clinical trial of Enstilar for psoriasis treatment
Babies treated for CMV infection for six months have better developmental outcomes